FDMT R&D Expense Growth
4D Molecular Therapeutics Inc · R&D Expense Growth
FDMT R&D Expense Growth
Latest reported38.50%period ending
FDMT FY R&D Growth (YoY) (0.00% → 38.50%)
Latest values, visible window
High-resolution chart · PNG
FDMT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 38.4978% | |
| 45.525% | |
| 20.9874% | |
| 30.7904% | |
| 15.6906% | |
| 20.9395% | |
| 138.8356% | |
| 35.2833% | |
| 0% |